FewerJobs.
All jobs

Director, US Medical Affairs, NSCLC

Revolution Medicines - Remote (United States)

Posted Nov 2, 2026

Benefits

Parental leave
Not verified
Non-birth-parent leave
Not verified
Family-building benefits
  • Fertility benefits: Not verified
  • Adoption assistance: Not verified
  • Surrogacy assistance: Not verified
Mental health support
Not verified
Relocation assistance
Not verified
Childcare support
Not verified
Learning budget
Not verified
Verification
Not verified checked Nov 20, 2026
Salary
$201K-$251K From the posting source checked Nov 18, 2026
401(k) match
Reported from DOL Form 5500 industry filing (not employer-specific)

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)
$81,444 U.S. median for this role
Projected growth (BLS Employment Projections)
+6.9% - Faster than average

177% above the BLS role benchmark for healthcare aggregate.

Matched to SOC 29-1141 - Healthcare aggregate by role bucket.

Source:U.S. Bureau of Labor Statistics, OEWS, May 2024andEmployment Projections, 2024-2034.

Role

Role function
Healthcare From the posting source checked Nov 18, 2026
Seniority
Director Plus From the posting source checked Nov 18, 2026
Work mode
Remote From the posting source checked Nov 18, 2026
In-office days
0 days From the posting source checked Nov 18, 2026

Schedule

Shift type
Not verified
Weekend work
Not verified

Company

Equity
Offered Verified - SEC 10-K source checked Nov 18, 2026

Application

Cover letter
Not verified
Assessment
Not verified
Deadline
Not stated

Where they hire

State eligibility is not yet verified.

About this role

Director, US Medical Affairs, NSCLC Remote (United States) Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide. Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor-all in service of patients. The Opportunity: The Director, US Medical Affairs - Non-Small Cell Lung Cancer (NSCLC) will support the development of the US medical strategy and lead execution of assigned medical priorities across the NSCLC portfolio. The role spans first-line and subsequent-line treatment settings and includes pre-launch planning, launch readiness, post-approval medical activities, and lifecycle planning. As a member of the US Medical Affairs Team (USMAT), the Director will translate evolving clinical evidence, external expert perspectives, and field insights into focused medical objectives and actionable plans. The individual will serve as an NSCLC scientific expert and partner across US and Global Medical Affairs, Field Medical, Clinical Development and Operations, Medical Information and Communications, HEOR/RWE, Biomarker and Companion Diagnostics, Commercial, Market Access, Patient Advocacy, Regulatory, Safety, Legal, and Compliance. The ideal candidate brings strong lung cancer expertise,

Read the full description at www.revmed.com. FewerJobs shows a preview and links to the original posting.

Apply at revmed.com

Apply link verified; last checked Nov 20, 2026.

What verified means

Verified means a displayed claim has field-level provenance to a source FewerJobs pulled: a government or employer source, or the original job posting. Posting-sourced facts are employer-stated and are labeled separately from government records.

Related jobs